Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual testosterone + tadalafil for women with hypoactive sexual desire disorder
NL-OMON36064Phase 2Active, not recruiting
- Sponsor
- Emotional Brain
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of testosterone and tadalafil in hypoactive sexual desire disorder (HSDD) and female sexual dysfunction (FSD), sponsored by Emotional Brain. Primary endpoint: Increase in sexual satisfaction of a single coital event. Started Jul 2011; status: active, not recruiting.
02
Drugs
testosteronetadalafil
03
Conditions
hypoactive sexual desire disorder (HSDD)female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NL-OMON36064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36064.